Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23420051)

1.

Investigation of the expression patterns and correlation of DNA methyltransferases and class I histone deacetylases in ovarian cancer tissues.

Gu Y, Yang P, Shao Q, Liu X, Xia S, Zhang M, Xu H, Shao Q.

Oncol Lett. 2013 Feb;5(2):452-458. Epub 2012 Dec 3.

2.

Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.

Hayashi A, Horiuchi A, Kikuchi N, Hayashi T, Fuseya C, Suzuki A, Konishi I, Shiozawa T.

Int J Cancer. 2010 Sep 1;127(6):1332-46. doi: 10.1002/ijc.25151.

PMID:
20049841
3.

Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.

Bai X, Song Z, Fu Y, Yu Z, Zhao L, Zhao H, Yao W, Huang D, Mi X, Wang E, Zheng Z, Wei M.

PLoS One. 2012;7(6):e40024. doi: 10.1371/journal.pone.0040024. Epub 2012 Jun 29.

4.

Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues.

Jin KL, Pak JH, Park JY, Choi WH, Lee JY, Kim JH, Nam JH.

J Gynecol Oncol. 2008 Sep;19(3):185-90. doi: 10.3802/jgo.2008.19.3.185. Epub 2008 Sep 30.

5.

Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.

Rajendran G, Shanmuganandam K, Bendre A, Muzumdar D, Goel A, Shiras A.

J Neurooncol. 2011 Sep;104(2):483-94. doi: 10.1007/s11060-010-0520-2. Epub 2011 Jan 13. Erratum in: J Neurooncol. 2011 Sep;104(2):495. Mujumdar, Dattatreya [corrected to Muzumdar, Dattatraya].

PMID:
21229291
6.

Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas.

Weichert W, Denkert C, Noske A, Darb-Esfahani S, Dietel M, Kalloger SE, Huntsman DG, Köbel M.

Neoplasia. 2008 Sep;10(9):1021-7.

7.

Correlations among PPARγ, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer.

Pazienza V, Tavano F, Benegiamo G, Vinciguerra M, Burbaci FP, Copetti M, di Mola FF, Andriulli A, di Sebastiano P.

PPAR Res. 2012;2012:461784. doi: 10.1155/2012/461784. Epub 2012 Aug 8.

8.

Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.

Girault I, Tozlu S, Lidereau R, Bièche I.

Clin Cancer Res. 2003 Oct 1;9(12):4415-22.

10.
11.

Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.

Thangaraju M, Carswell KN, Prasad PD, Ganapathy V.

Biochem J. 2009 Jan 1;417(1):379-89. doi: 10.1042/BJ20081132.

12.

Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.

Xiong Y, Dowdy SC, Xue A, Shujuan J, Eberhardt NL, Podratz KC, Jiang SW.

Gynecol Oncol. 2005 Mar;96(3):601-9.

PMID:
15721400
13.

Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins.

Mirza S, Sharma G, Parshad R, Gupta SD, Pandya P, Ralhan R.

J Breast Cancer. 2013 Mar;16(1):23-31. doi: 10.4048/jbc.2013.16.1.23. Epub 2013 Mar 31.

14.

Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts.

Casillas MA Jr, Lopatina N, Andrews LG, Tollefsbol TO.

Mol Cell Biochem. 2003 Oct;252(1-2):33-43.

PMID:
14577574
15.

DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.

Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN.

Int J Mol Med. 2007 Jul;20(1):65-73.

PMID:
17549390
16.

Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma.

Zhang JJ, Zhu Y, Zhu Y, Wu JL, Liang WB, Zhu R, Xu ZK, Du Q, Miao Y.

Clin Transl Oncol. 2012 Feb;14(2):116-24. doi: 10.1007/s12094-012-0770-x.

PMID:
22301400
17.

DNMT1 and HDAC1 gene expression in impaired spermatogenesis and testicular cancer.

Omisanjo OA, Biermann K, Hartmann S, Heukamp LC, Sonnack V, Hild A, Brehm R, Bergmann M, Weidner W, Steger K.

Histochem Cell Biol. 2007 Feb;127(2):175-81. Epub 2006 Sep 8.

PMID:
16960727
18.

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.

Weichert W, Röske A, Gekeler V, Beckers T, Stephan C, Jung K, Fritzsche FR, Niesporek S, Denkert C, Dietel M, Kristiansen G.

Br J Cancer. 2008 Feb 12;98(3):604-10. doi: 10.1038/sj.bjc.6604199. Epub 2008 Jan 22.

19.

Clinical significance of the expression of DNA methyltransferase proteins in gastric cancer.

Yang J, Wei X, Wu Q, Xu Z, Gu D, Jin Y, Shen Y, Huang H, Fan H, Chen J.

Mol Med Rep. 2011 Nov-Dec;4(6):1139-43. doi: 10.3892/mmr.2011.578. Epub 2011 Aug 31.

PMID:
21887466
20.

Histone deacetylase 1 mRNA expression in lung cancer.

Sasaki H, Moriyama S, Nakashima Y, Kobayashi Y, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y.

Lung Cancer. 2004 Nov;46(2):171-8.

PMID:
15474665
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk